At-home brain stimulation has FDA approval, but clinical proof remains thin
The FDA’s clearance of Flow Neuroscience’s at-home transcranial direct-current stimulation headset marks a notable step for neuromodulation as a depression treatment, but the evidence remains more suggestive than decisive, reports the New York Times. The device delivers a weak electric current to the brain and is being promoted